News stories about Validus (NYSE:VR) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Validus earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned headlines about the insurance provider an impact score of 46.3880555570015 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of research firms have weighed in on VR. Keefe, Bruyette & Woods upgraded Validus from a “market perform” rating to an “outperform” rating in a research note on Thursday. UBS Group raised their price target on Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Bank of America upgraded Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. ValuEngine upgraded Validus from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Finally, Barclays cut their price target on Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Monday, October 16th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $54.83.

Shares of Validus (NYSE:VR) opened at $46.49 on Friday. The company has a current ratio of 0.95, a quick ratio of 0.95 and a debt-to-equity ratio of 0.52. Validus has a 52-week low of $41.15 and a 52-week high of $58.76. The company has a market capitalization of $3,690.00, a PE ratio of -71.52, a PEG ratio of 1.23 and a beta of 0.67.

Validus (NYSE:VR) last posted its earnings results on Thursday, October 26th. The insurance provider reported ($3.22) EPS for the quarter, topping the Zacks’ consensus estimate of ($3.30) by $0.08. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. The business had revenue of $407.00 million for the quarter, compared to analysts’ expectations of $453.04 million. During the same quarter in the previous year, the firm earned $1.02 earnings per share. The business’s revenue was up 24.3% compared to the same quarter last year. research analysts forecast that Validus will post -0.24 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were given a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.27%. The ex-dividend date of this dividend was Thursday, December 14th. Validus’s dividend payout ratio (DPR) is currently -233.85%.

In related news, CEO Lixin Zeng sold 26,136 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the transaction, the chief executive officer now owns 57,855 shares of the company’s stock, valued at $3,014,245.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Kean Driscoll sold 6,875 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $46.16, for a total value of $317,350.00. Following the transaction, the president now directly owns 110,858 shares in the company, valued at approximately $5,117,205.28. The disclosure for this sale can be found here. Insiders have sold 39,886 shares of company stock worth $2,024,848 in the last quarter. Insiders own 2.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at

Validus Company Profile

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with's FREE daily email newsletter.